Clinical Trials in Salt Lake City

Showing 4621-4640 of 16,694 trials

VAY736 in Combination With Ibrutinib in Patients With CLL on Ibrutinib

NCT03400176

Patients enrolled to the study had chronic lymphocytic leukemia (CLL) and received ibrutinib. Patients had either received ibrutinib for one year without having had a complete response or patients developed a resistance mutation to ibrutinib. This study had two parts, a dose escalation part and a dose expansion part.

Chronic Lymphocytic Leukemia (CLL)

Novartis Pharmaceuticals39 participantsStarted Apr 2018

La Jolla, California, United States • Los Angeles, California, United States • Columbus, Ohio, United States +2 more locations

Active Not RecruitingPhase 2/3< 1 mile

A Study of a Patient-Specific Neoantigen Vaccine in Combination With Immune Checkpoint Blockade for Patients With Metastatic Colorectal Cancer

NCT05141721

The primary objective of the Phase 2 portion of the study is to characterize the clinical activity of maintenance therapy with GRT-C901/GRT-R902 (patient-specific vaccines) in combination with checkpoint inhibitors in addition to fluoropyrimidine/bevacizumab versus a fluoropyrimidine/bevacizumab alone as assessed by molecular response which is based on changes in circulating tumor (ct)DNA. The primary objective of the Phase 3 portion is to demonstrate clinical efficacy of the regimen as assessed by progression-free survival.

Colorectal Neoplasms

Seattle Project Corporation700 participantsStarted Feb 2022

Gilbert, Arizona, United States • Springdale, Arkansas, United States • Los Angeles, California, United States +40 more locations

VAY736 in Combination With Ibrutinib in Patients With CLL on Ibrutinib

A Study of a Patient-Specific Neoantigen Vaccine in Combination With Immune Checkpoint Blockade for Patients With Metastatic Colorectal Cancer

Find Trials by Condition in Salt Lake City

First-in-Human Study of RLY-5836 in Advanced Breast Cancer and Other Solid Tumors

KidneyCare Cohort Study (KCC-S)

Sequential and Comparative Evaluation of Pain Treatment Effectiveness Response

Efficacy, Safety and Tolerability of Balcinrenone/Dapagliflozin Compared to Dapagliflozin in Adults With Chronic Kidney Disease

Study of TH-302 or Placebo in Combination With Pemetrexed in Patients With Non-squamous Non-small Cell Lung Cancer

A Second Intermediate-Size Expanded Access Protocol (EAP) for Pridopidine in People With Amyotrophic Lateral Sclerosis (Pridopidine EAP 2)

Early Integrated Telehealth Versus In-Person Palliative Care for Patients With Lung Cancer

Study of Efficacy, Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) of an Anti-CD40 Monoclonal Antibody, CFZ533, in Liver Transplant Recipients With Additional 12-month Follow-up and Long-term Extension

A Trial Evaluating the Safety and Effects of an RNA Vaccine ARCT-021 in Healthy Adults

Safety, Tolerability and Pharmacokinetics Study of KPG-818 in Hematological Malignancies Subjects

Study of Safety, Efficacy and Tolerability of Secukinumab Versus Placebo, in Combination With SoC Therapy, in Patients With Active Lupus Nephritis

A Study of IMR-687 in Subjects With Sickle Cell Disease

Cognition and Imaging With Tigertriever

Natural Versus Programmed Frozen Embryo Transfer (NatPro)

A Study to Assess Real-world Patient Characteristics and Clinical Course for Symptomatic Patients With PKP2-ACM

Natural Sunlight Protection and Simulated Sunlight Protection Offered by Sunscreens and Fabrics

PRimary Care Opioid Use Disorders Treatment (PROUD) Trial

Pulmonary Embolism International THrOmbolysis Study-3